Project Grant W81XWH2210541
Award Date 7/1/22
Completion Date 8/31/25
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- The federal Project Grant award of $591,096.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at the St. Vincent's Institute of Medical Research in Australia. The goal of the research is to prevent bone marrow failure in Fanconi anemia through FANCM inhibition. The award has a performance period from July 15, 2025 to July 14, 2028. The St. Vincent's Institute of Medical Research is a foreign-owned, non-profit...
- This federal Project Grant award, titled "PREVENTION OF BONE MARROW FAILURE IN FANCONI ANEMIA THROUGH FANCM INHIBITION," is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $239,856 grant, awarded on July 15, 2025, supports advanced biomedical research conducted by the University of Sydney in Australia. The project aims to investigate innovative medical solutions for preventing bone marrow failure in Fanconi anemia, a...
- The Department of the Army Medical Command awarded a $519,702 Project Grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The two-year grant will support Stanford's development of non-genotoxic hematopoietic stem cell transplantation regimens for Fanconi anemia. Fanconi anemia is a rare genetic disorder that can cause bone marrow failure and blood cancers. The Military Medical Research and Development program aims to advance medical solutions...
- This $1,046,250.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support the Regents of the University of Minnesota in conducting a comprehensive research project titled "CHARACTERIZATION AND IN VIVO GENE THERAPY USING A NOVEL FANCONI ANEMIA MOUSE MODEL OF BONE MARROW FAILURE." The 3-year project, running from November 1, 2024 to October 31, 2027, will leverage the university's expertise in advanced...
- The U.S. Defense Health Agency has awarded a $367,622 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to St. Vincent's Institute of Medical Research, a foreign-owned non-profit organization based in Australia. The grant supports a 2-year research project focused on studying the reprogramming of mRNA translation as a driver of drug resistance in ovarian cancer. The research aims to transform healthcare for military service members and the broader public...
- The Department of Defense's Defense Health Agency awarded a $783,191 Project Grant to the Regents of the University of Minnesota (UEI: KABJZBBJ4B54) under the Military Medical Research and Development program (CFDA 12.420). The grant supports in vivo gene therapy research for Fanconi anemia, a rare genetic disorder, with a performance period from September 1, 2025 to August 31, 2028. As a prominent research institution, the University of Minnesota will leverage its academic expertise and...
- The University of Queensland in Australia was awarded a $520,011 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 on a novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The Department of the Army Medical Command awarded $608,341 to Monash University under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2022 through September 14, 2025. The project grant funding will support Monash University's research efforts to elucidate and suppress cells of origin of cutaneous melanoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The Department of the Army Medical Command awarded a $715,500 project grant to Children's Hospital Medical Center in Cincinnati, Ohio from September 1, 2022 through August 31, 2025. The grant supports research titled "Human and Mouse Models of DDX41-Mutated Myelodysplastic Syndrome" under the Military Medical Research and Development program (CFDA 12.420). This project aims to investigate medical solutions for the battlefield by transforming health care through innovative biomedical...
- The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...